How Do Iranian Stakeholders Think About Pharmaceutical Managed Entry Agreements?

Nikta Shobeiri Farzad Peiravian Nazila Yousefi

Published in: Iranian journal of pharmaceutical research : IJPR (2022)

Efficient implementation of MEAs depends on the weaknesses and threats and considering the views of relevant stakeholders. Constructive interaction among all stakeholders is essential for adequately executing MEAs.

Keyphrases

primary care
healthcare
quality improvement